National Centre for Healthcare Research and Pharmacoepidemiology, Department of Statistics and, Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Department of Statistics and Quantitative Methods, Division of Biostatistics, Epidemiology and Public Health, Laboratory of Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Expert Rev Clin Pharmacol. 2022 Jun;15(6):779-785. doi: 10.1080/17512433.2022.2092471. Epub 2022 Jun 21.
Antibiotic exposure may be associated with atopic dermatitis (AD). We assessed the risk of developing AD among children early exposed to antibiotics.
From the Italian Pedianet database, children aged 0-14 years between 2004-2017 were enrolled from birth up to at least one year. Cox proportional-hazards models were fitted to estimate Hazard Ratios (HR) and 95% Confidence Intervals (CI) for the association between antibiotic exposure during the first year of life with incident AD. Exposure was also considered as a time-varying variable.
73,816 children were included in the final cohort, of which 34,202 had at least one antibiotic prescription. Incident AD was present in 8% of unexposed and exposed children. Early antibiotic exposure was not associated with any excess risk of AD compared to unexposed children (HR: 1.02, 95% CI: 0.97-1.07), and no dose-response effect was observed. In the time-varying analysis, antibiotic exposure was significantly associated with AD onset (1.12, 1.07-1.17). However, when taking into account the time-lag between exposure and outcome, risks progressively decreased, suggesting possible protopathic bias.
These results are not suggestive of any significant association between exposure to antibiotics and subsequent AD onset and support the possible presence of protopathic bias.
抗生素暴露可能与特应性皮炎(AD)有关。我们评估了早期接触抗生素的儿童发生 AD 的风险。
从意大利 Pedianet 数据库中,纳入了 2004 年至 2017 年间出生至至少 1 岁的 0-14 岁儿童。使用 Cox 比例风险模型来估计生命第一年抗生素暴露与新发 AD 之间的关联的风险比(HR)和 95%置信区间(CI)。暴露也被视为一个时变变量。
最终队列纳入了 73816 名儿童,其中 34202 名儿童至少有一次抗生素处方。未暴露和暴露组中分别有 8%和 10%的儿童发生新发 AD。与未暴露儿童相比,早期抗生素暴露与 AD 风险增加无关(HR:1.02,95%CI:0.97-1.07),也未观察到剂量反应关系。在时变分析中,抗生素暴露与 AD 发病显著相关(1.12,1.07-1.17)。然而,当考虑到暴露和结局之间的时间滞后时,风险逐渐降低,提示可能存在前驱性偏倚。
这些结果不提示抗生素暴露与随后的 AD 发病之间存在任何显著关联,并支持可能存在前驱性偏倚。